Aspiriant LLC’s Textron TXT Stock Holding History

Aspiriant LLC’s Portfolio TXT Stock Details TXT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$423K	Buy	4,606 +2,302	+100%	+$209K	0.01%	270
2026 Q1	$202K	Buy	+2,304	New	+$215K	0.01%	334

Other funds holding TXT

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Aspiriant LLC's TXT Position: Q2 2026 in Review

Aspiriant LLC increased its Textron (TXT) stake by 100% in Q2 2026, buying an estimated $209K and bringing the position to 4,606 shares worth $423K. The position accounts for 0.01% of the portfolio, ranked #270.

Aspiriant LLC first reported a position in TXT in Q1 2026 and has held it in 2 quarters since. 791 funds tracked by Wall St. Rank hold TXT as of Q2 2026.

Aspiriant LLC held 4,606 shares of Textron worth $423K as of Q2 2026.
Aspiriant LLC bought 2,302 Textron shares in Q2 2026, an estimated $209K.
Textron made up 0.01% of Aspiriant LLC's portfolio in Q2 2026, its #270 holding.
Aspiriant LLC first reported a position in Textron in Q1 2026 and has held it in 2 quarters since.
791 funds tracked by Wall St. Rank held Textron as of Q2 2026.

Based on Aspiriant LLC's 13F filing for Q2 2026, filed 20 Jul 2026.